Beyond Unit Cost: Evaluating Clinical Programs and Capabilities of PBMs
Read the full article by AlignRx COO Greg Sanderson on Employee Benefit News. Drug pricing is typically the main factor brokers and employer groups consider when evaluating PBMs. It makes sense. In a highly complex marketplace, their primary focus is getting their members’ prescriptions filled for the lowest price. But projecting – and ultimately lowering […]
Beyond Unit Cost: Evaluating Clinical Programs and Capabilities of PBMs Read More »
